Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Thursday, September 9, 2010

1993 Mitchell TMAU paper : The fish odour syndrome: biochemical, familial, and clinical aspects

This is an interesting TMAU paper from 1993 by a TMAU expert mostly involved in studies that looked at biochemical aspect of TMAU amongst body odor sufferers, Dr Stephen Mitchell of London. Unfortunately he no longer seems to do such research.

Not much seems to have changed since 1993, apart from now they have a test for the genotype testing (DNA test), and also perhaps the 'reference range' in the urine test has come down to a lower level ? In this paper, most of the TMAU cases are regarded positive if their result was around 50% or less. Perhaps today, the borderline is set at around 85% ? The paper seems to have come about due to an article in a UK newspaper in 1991. It resulted in 187 body odor sufferers writing to Dr Mitchell, who then did a survey of them, including a TMAU urine test for 156 of them. Of the 156, 11 were regarded as obvious TMAU cases (using the reference range of the time).

Of the 11 TMAU cases, 6 of them had their parents do the TMAU 'carrier' test (taking 600mg of TMA), which they all 'failed'. Another interesting point is that the 11 cases has TMA levels in the 100's, which seems on the high side.

The fish odour syndrome: biochemical, familial, and clinical aspects.
Ayesh R, Mitchell SC, Zhang A, Smith RL.

Department of Pharmacology and Toxicology, St Mary's Hospital Medical School, (Imperial College), London.
Comment in:

BMJ. 1993 Oct 16;307(6910):1009.
BMJ. 1993 Sep 11;307(6905):639-40.
OBJECTIVES: To study the biochemical, familial, and clinical features of the fish odour syndrome among subjects with suspected body malodour.

DESIGN: Subjects who responded to a newspaper article were screened for the fish odour syndrome by interview and biochemical tests. Families of subjects with the syndrome were tested if possible.

SETTING: St Mary's Hospital, London, and some interviews at subjects' homes.

SUBJECTS: 187 subjects (28 males) with suspected body malodour, of whom 156 (19 males) underwent biochemical tests. Five families of six of the subjects with the fish odour syndrome agreed to further tests.

MAIN OUTCOME MEASURES: Amounts of trimethylamine and trimethylamine N-oxide in urine collected over 24 hours under normal dietary conditions and for eight hours after oral challenge with 600 mg trimethylamine.

RESULTS: The fish odour syndrome was diagnosed in 11 subjects: the percentage of total trimethylamine excreted in their urine samples that was oxidised to trimethylamine N-oxide was < 55% under normal dietary conditions and < 25% after oral challenge with trimethylamine (in normal subjects > 80% of trimethylamine was N-oxidised). Parents of six of the subjects with the syndrome were tested: all showed impaired N-oxidation of excreted trimethylamine (< 80%) after oral challenge, indicating that they were heterozygous carriers of the allele for the syndrome. The syndrome was associated with various psychosocial reactions including clinical depression. CONCLUSIONS: The fish odour syndrome can be inherited in an autosomal recessive fashion. It should be considered as a possible causative factor in patients complaining of body malodour. 
Full paper : The fish odour syndrome: biochemical, familial, and clinical aspects


Post a Comment